Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase II trial under way for TNX-355 for HIV

May 10, 2004

Two series of chemokine CCR5 antagonists and their use in HIV infection

May 10, 2004

Ono scientists describe new chemokine CCR5 antagonists and their therapeutic use

May 10, 2004

Safety and pharmacokinetic profile of PL-100

May 7, 2004

PRO-140 viral entry inhibitor enters phase I

May 6, 2004

Antiretroviral spermicide WHI-07 effective against FIV transmission in domestic cats

May 6, 2004

New non-nucleoside HIV RT inhibitors identified at Boehringer Ingelheim

May 4, 2004

SBIR supports development of gp41 inhibitors at Locus

May 3, 2004

Good safety and pharmacokinetic profile of AMD-070 in healthy volunteers

May 3, 2004

Second stage entered in phase I study of SPL-7013

April 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...